Albany Med's Cancer Treatment Noted for Better Outcomes, Higher Quality
ALBANY, N.Y., February 5, 2013—The five-year survival rates for women treated for stage II breast cancer at Albany Medical Center are nearly 7 percent higher than the average of other academic medical institutions, according to data released by the American College of Surgeons.
In addition, Albany Medical Center follows best practices for treatment of breast and colon cancer at rates far higher than cancer treatment centers both in New York State and across the country.
“Albany Medical Center’s breast program provides a multidisciplinary approach to meet each individual patient’s needs,” said Donna M. Pietrocola, M.D., F.A.C.S., chief of the section of breast and endocrine surgery at Albany Medical Center. “We have state-of-the-art technologies and a full range of surgical capabilities as well as the support of medical and radiation oncologists to provide the best possible care and outcomes for patients battling breast cancer.”
“Patients who receive treatments for their cancers at Albany Med can be assured that they are being treated by a world-class team of specialists who follow the best practices available and collaborate to find the most appropriate patient-specific therapy to allow for the greatest chance of success,” said Ankesh Nigam, M.D., director of the surgical oncology program at Albany Medical Center.
The nationwide oncology outcomes database is used to track and analyze data to explore trends in cancer care, create regional and state benchmarks for participating hospitals, and serve as the basis for quality improvement. The report released today reflects data from 2010, the most recent full year available. Issued by the American College of Surgeon’s Commission on Cancer (COC), the survey includes data from nearly 1,400 COC-accredited cancer treatment centers across the country, including 70 within New York State.
The types of practices noted include approaches for administration of appropriate radiation therapies, combination chemotherapies, and Tamoxifen or other medications for breast cancers; and administration of appropriate chemotherapies or removal of lymph nodes for colon cancer.
The Commission on Cancer was established by the American College of Surgeons in 1922. It is a consortium of professional organizations dedicated to improving survival and quality of life for cancer patients through standard setting, prevention, research, education, and the monitoring of comprehensive quality care. Albany Medical Center’s cancer program has been continuously accredited by the Commission on Cancer since 1938.
Albany Medical Center, northeastern New York’s only academic health sciences center, is one of the largest private employers in the Capital Region. It incorporates the 651-bed Albany Medical Center Hospital, which offers the widest range of medical and surgical services in the region, and the Albany Medical College, which trains the next generation of doctors, scientists and other healthcare professionals, and also includes a biomedical research enterprise and the region’s largest physicians practice with 350 doctors. Albany Medical Center works with dozens of community partners to improve the region’s health and quality of life. For more information: www.amc.edu or www.facebook.com/albanymedicalcenter.
Statistical information presented in press releases may no longer be valid.